. Several authors have reported that certain steps of the metastatic cascade are rate limiting (Hart et al., 1989; Fidler, 1990; Fidler and Radinski, 1990; Kerbel, 1990; Fodstad, 1993 Cell isolation was performed as described . Briefly, livers from anaesthetised tumour-bearing mice were washed in situ by perfusion through the portal vein at 37°C with 10 ml a modified Eagle medium (MEM) containing 15 mM Hepes at a flow rate of 3 ml min-'. Tissue digestion was carried out during perfusion with 10 ml of x-MEM/Hepes containing 0.05% pronase E (Boehringer Mannheim, Germany) at 1 ml min-' and then with 15 ml Correspondence: M Rocha
The interaction between tumour and host cells determines to a large extent the outcome, namely tumour growth and progression towards metastases or tumour arrest, dormancy or rejection. Most of the studies published so far on interactions of tumour cells and host cells were made in vitro and dealt with aspects such as cell adhesion, proliferation, invasiveness, cytotoxicity or cytokine production. Since the microenvironment in tissue culture differs in many respects from that in vivo, new approaches for in vivo studies of tumour -host cell interactions are of utmost importance in cancer research.
To elucidate the metastatic phenotype, approaches have been made to relate, for instance, cell surface molecules expressed on the tumour cell lines from tissue culture to their propensity to generate metastases in vivo (Nicolson 1982 (Nicolson , 1987 . Several authors have reported that certain steps of the metastatic cascade are rate limiting (Hart et al., 1989; Fidler, 1990; Fidler and Radinski, 1990; Kerbel, 1990; Fodstad, 1993) . To (liver, spleen, etc.) by staining with 5-bromo-4-cloro-3 indoyl-fl-D-galactopyranoside (X-Gal) or as live cells after tissue dissociation staining with fluorescein-di-fl-galactopyranoside (FDG) (Kruiger et al., 1994a) . In this ESbL-lacZ tumour model, intradermal tumour growth and liver metastasis development followed three distinct phases: a first exponential growth phase, a transient plateau phase and a second expansion phase. The plateau phase was characterised by a constant tumour diameter, correlating with a constant low amount of metastasis in the liver. This phase was followed by an aggressive second expansion phase leading to macroscopic metastases in multiple visceral organs and to death of the animals within a few days (Kruger et al., 1994b of the same medium containing 0.03% pronase E, collagenase A (from Clostridium hystolyticum, Boehringer Mannheim). After perfusion, livers were minced and stirred in 13 ml a-MEM/Hepes containing 0.04% pronase E, 0.04% collagenase and 0.0004% DNAase (Sigma Chemical Co., USA) at 37°C for 10 min. The cell suspension was then filtered through a nylon gauze and centrifuged at 300 g for 10 min. To remove cell debris and erythrocytes, the cell pellet was centrifuged at 1400 g for 15 min in oa-MEM/Hepes containing 17.5% (w/v) metrizamide (Sigma Chemical Co.), followed by washing of the top layer with ax-MEM/Hepes at 300 g for 10 min. .
Isolation and enrichment of tumour and host cell populations from metastatic organs for studies at the transcriptional level After in vivo liver perfusion and metrizamide gradient centrifugation, the isolated total sinusoidal cell population (Figure 2 ). The non-adherent cells were removed and seeded over glutaraldehyde-pretreated dishes, which has been described as being an effective method to obtain Kupffer cells with a high purity (Smedsrod et al., 1985) . Since the viability of the separated population decreased dramatically with time in culture, we decided that 30 min was the optimal time in terms of cell yield and viability. The number of Kupffer cells obtained was between 35% and 40% of the total seeded population (Figure 2 ). Both endothelial and Kupffer cell fractions were scraped off with a rubber policeman, pelleted and snap frozen to avoid RNA destruction by RNAases (Figure 2 ). The remaining non-adherent cell suspension was a mix of lymphocytes and lacZ-tagged tumour cells. FDG loading of the cell suspension and FACS cell separation was performed as described in Materials and methods. At day 28 after intradermal ESbL-IacZ tumour cell inoculation, the number of tumour cells in the liver approximated 15 -25% of the total population and that of the lymphocytes about 10 -15% ( Figure  2) .
As a second metastasised organ we investigated the spleen. Spleen macrophages were isolated from the single cell suspension by plastic adherence. The remaining supernatant, containing lymphocytes and tumour cells, was stained with FDG and sorted as described above. Figure 3 shows examples of the analysis of gene expression of different cellular subpopulations isolated from metastatic spleens or livers. Lymphocytes isolated from control spleens and from metastatic spleens at the plateau phase (day 16) and at the end of the metastatic process (day 28) showed differences at the RNA level with regard to expression of distinct molecules, such as MHC class II a chain (Figure 3a  and b Figure 3c and d, expression of ICAM-1 was down-regulated at day 16 in both experiments (40% and 35% respectively) and less so at day 28, compared with the control. This differential expression if ICAM-1 in endothelial cells isolated from metastatic livers at different time points has been observed previously also at the protein level .
Analysis of Kupffer cells (Figure 3e and f) Isolated tumour cells were studied for the expression of different molecules potentially involved in metastasis formation. We found differences, as shown in Figure 3g and h, in expression of In conclusion, our method provides a new tool to study expression changes at the RNA and protein level of molecules potentially involved in metastasis progression or inhibition.
Discussion
Organotropism, i.e. the preference of certain cancers to metastasise to certain organs and tissue-specific metastasis patterns are quite often seen in clinic samples and in experimental tumour models. Both phenomena underline the importance of local microenvironmental factors for the development of metastases (Fidler, 1986; Liotta, 1986; Hoffman, 1992) . Several studies correlated phenotypic features of tumour cells before being injected into animals with the final outcome of metastasis and formed the basis for terms such as the 'metastatic phenotype' (Kerbel 1990; Fidler, 1990) . Also, in recent years the concept of 'dynamic heterogeneity' was introduced. It suggests that the metastatic phenotype, although it is a genetically controlled trait, is inherently dynamic or unstable (Weiss et al., 1980; Ling et al., 1985; Vaage, 1988) . Because of this phenotypic instability, an adequate methodology has to be established for direct typing of tumour cells at distinct stages of the metastatic process without in vitro culture.
We have established a new methodology for the study of tumour-host interactions in the metastatic process. Firstly, we used a tumour cell line transduced with the bacterial gene lacZ, to study tumour-host interactions, for instance during micrometastasis, minimal residual disease or tumour dormancy. Secondly, we have established a method allowing the separation of tumour and host cells from the liver and spleen with a high viability (93-95%) and reproducibility which can be used for different target organs. This permits the direct characterisation of ex vivo isolated cells without further in vitro culture. Control experiments in reisolated and cultured tumour cells showed that the FDG technique is very specific and sensitive, since all the tumour cells express the lacZ gene after being grown in vivo. This excludes the possibility of the existence of lacZ-revertant tumour cells which could not be detected and quantified as tumour cells.
The described technique provides the possibility of studying molecules involved in the metastatic process at two different levels, mRNA and protein (for instance, adhesion molecules, homing receptors, immune stimulatory molecules, etc.). Malignant cells disseminate from a locally growing tumour to other sites by means of adhesion molecules (e.g. LFA-1, ICAM-1, VLA-4) and homing receptor molecules (e.g. which are used by haemopoietic normal cells for traffic and localisation in various organs or at sites of inflammation. It has been suggested, for example, that the adhesion of melanoma cells to activated endothelium is mediated by VLA-4 receptors, thus implicating this adhesion molecule in metastatic process (Garofalo et al., 1995) . Our results, however, showed that the VLA-4 molecule was down-regulated in the ESbL-lacZ tumour cells when injected into syngeneic animals. Evidence that LFA-1 and ICAM-1 are involved in metastatis has also been presented (Zalhaka et al., 1993; Harning et al., 1993) . In support of these observations, we have recently shown by using this new methodology that the expression of LFA-1 and ICAM-1 molecules was up-regulated during the progressive phase of tumour growth and metastasis in the ESbL-lacZ lymphoma model . Consequently, a strategy was developed to apply antibodies against these adhesion molecules before the final progressive phase of tumour growth started. Such experiments resulted in complete inhibition of tumour progression in vivo .
The results from Figure 3 show that the expression of adhesion molecules such as ICAM-1 in endothelial cells or VLA-4 in metastasising tumour cells is regulated in vivo at the RNA level. This method of analysis may thus provide a possibility of determining which molecules and which window in time may be suited for therapeutical intervention.
Other molecules such as costimulatory molecules, MHC class I or class II and CD80 (B7-1), which have been reported to be important in the recognition of the tumour cells by the immune system (Becker et al., 1993; Chen et al., 1992) , can also be studied by this method during the whole process of tumour growth and metastasis. The observed down-regulation of MHC class II RNA in lymphocytes from metastatic spleens at a late stage of metastasis could lead to a decrease of recognition of tumour-associated antigens on tumour cells, hampering an effective immune response.
Northern and slot blot techniques allowed the study of molecules of importance in metastasis. There have been numerous reports showing that the metastatic potential of tumours may correlate directly with the expression level of distinct genes. Some genes coded for adhesion and costimulatory molecules (Becker et al., 1993; Chen et al., 1992) , others for growth factors, growth factor receptors, enzymes or multidrug resistance (bFGF, EGFR, type IV collagenase or mdr-1) (Fidler, 1995) . In this study, the differential expression of genes coding for VLA-4, ICAM-1 and MHC class II on tumour and host cells was closely associated with metastatic progression or growth retardation.
The technique provides new possibilities of using ex vivo isolated cells for different purposes. Ex vivo isolated metastasised tumour cells can be used for cell-cell interaction studies with different host cells, for investigation of cytokine and growth factor production and as target cells in cytotoxicity assays with ex vivo isolated lymphocytes or macrophages. Endothelial and Kupffer cells provide a tool for adhesion studies with tumour cells (Asumendi et al., 1996) and for evaluation of the production of different cytokines and cytotoxic molecules. One example of cytotoxic substances produced by activated host cells is nitric oxide (NO) Umansky et al., 1995) . NO has been identified recently as an effector molecule of cytotoxicity mediated by macrophages and endothelial cells (Hibbs et al., 1988) . Its toxic effect is a result of inhibition of DNA synthesis and of Figure 3 Slot blot analysis of gene expression of different cellular subpopulations isolated from metastatic spleens or livers of EsblacZ tumour bearing mice. Organs were removed from either normal mice (control) or from tumour-bearing mice 16 days or 28 days after intradermal tumour cell transplantation. Tumour and host cells were separated and total RNA prepared as described in Figure  2 . The different RNAs were blotted onto nitrocellulose and hybridised with test probes for MHC class II a chain (a), ICAM-1 (c), MHC class II ,B chain (e), growth and metastasis. This experimental approach opens a broad possibility for studies of the basic mechanisms of tumour development, for example: (1) evaluation of vaccination effects in target organs; (2) determination of the right window in time for cancer therapy; and (3) investigation of the effects of transferred immune cells, tissues or organs on the host, for instane in the processes of graft vs leukaemia and graft vs host disease . Work is now in progress on the establishment of methods allowing the separation of host and tumour cells from human primary tumours and metastasis.
